CJC-1295 with DAC - Research Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH), developed for research into extended growth hormone stimulation. The addition of DAC significantly increases the peptide's half-life, enabling sustained GH release over several days. This makes it ideal for studies into continuous GH elevation, anti-aging mechanisms, and regenerative biology.

Download Third Party COA: CJC-1295 COA - Batch 19430
Independently verified by Janoshik, Batch 19430 is tested for >99% purity. Each vial is labelled for full traceability and research transparency.

• Batch Number: 19430
• Molecular Formula: C165H269N47O46
• Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser + DAC
• Research Only: Yes
• Purity: 99%+
• Form: Lyophilised Solid
• Mixing Water Required: Yes

Usage and Storage:

CJC-1295 with DAC is supplied as a lyophilised powder for enhanced stability. Store in a cool, dry place away from direct sunlight. After reconstitution with sterile or bacteriostatic water, refrigerate and use within the advised timeframe.

Peptide Mixing Notes

Let both the peptide vial and mixing solution reach room temperature before reconstitution. Swirl gently to dissolve; do not shake, as this may degrade the peptide.